Each uncoated bilayer tablet contains:
Teneligliptin Hydrobromide Hydrate IP
Equivalent to Teneligliptin 20 mg
(as sustained release ) IP 500 mg
Diabetes may cause many complications and causes disability, reduces the quality of living and premature death.so, this composition offers benefits and effectively treats short term and long-term complications.
In type-2 diabetes mellitus
Teneligliptin is a dipeptidyl peptidase 4 inhibitor. It is used along with exercise and diet for the control of blood sugar level
Metformin is a biguanide and it prevents the damage of kidney and blindness and problems in nerves, loss of limbs and sexual functional problems.
Mechanism of Action
It increases the release of insulin from the pancreas and causes the decrease in the release of hormone that raises the blood sugar levels.
It delays the absorption of glucose from the intestine and increases the sensitivity to insulin or lowers the production of glucose from liver.
It is absorbed via GIT
It is 90% bound to plasma proteins
It is metabolized in the liver
It is excreted via urine
- Stomach upset
- Sore throat
- Congestion of nose
- Contraindicated in people with renal impairment
- Contraindicated in people with known hypersensitivity